Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
B.A.J. Ponder.
Cancer genetics.
Nature, 411 (2001), pp. 336-341
[2.]
M.P. Smith.
Exploring molecular biology. An older surgeon looks at a new universe.
Arch Surg, 130 (1995), pp. 811-816
[3.]
D.M. Miltenburg, L. Conklin, S. Sastri.
The role of genetic screening and prophylactic surgery in surgical oncology.
J Am Coll Surg, 190 (2000), pp. 619-628
[4.]
G.M.E. Humphrey, R. Squire, M. Lansdown, A. Markham, K. MacLennan.
Cytogenetics and the surgeon: an invaluable tool in diagnosis, prognosis and counselling of patients with solid tumours.
Br J Surg, 85 (1998), pp. 725-734
[5.]
B.A.J. Ponder.
Cost, benefits and limitations of genetic testing for cancer risk.
Br J Cancer, 80 (1999), pp. 46-50
[6.]
J.L. Ivanovich, T.E. Read, D.J. Ciske, I.J. Kodner, A.J. Whelan.
A practical approach to familiar and hereditary colorectal cancer.
Am J Med, 107 (1999), pp. 68-77
[7.]
D.L. Learoyd, M. Messina, J. Zedenius, B.G. Robinson.
Molecular genetics of thyroid tumors and surgical decision-making.
World J Surg, 24 (2000), pp. 923-933
[8.]
M.L. Brandi, R.F. Gagel, A. Angeli, J.P. Bilezikian, P. Beck-Peccoz, C. Bordi.
Guidelines for diagnosis and therapy of MEN type 1 and type 2.
J Clin Endocrinol Metab, 86 (2001), pp. 5658-5671
[9.]
C. Sebastian, J.L. Ponce, M. Meseguer, F. Carbonell, P. González, F. Martínez, et al.
Feocromocitoma bilateral asociado a Von Hippel-Lindau: estudio genético.
Cir Esp, 72 (2002), pp. 244-245
[10.]
G.M. Petersen, J.D. Brensinger, K.A. Johnson, F.M. Giardiello.
Genetic testing and counselling for hereditary forms of colorectal cancer.
Cancer, 86 (1999), pp. 2540-2550
[11.]
J.P. Evans, C. Skrzynia, W. Burke.
The complexities of predictive genetic testing.
BMJ, 322 (2001), pp. 1052-1056
Copyright © 2002. Asociación Española de Cirujanos
